Amedisys, Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 3 | $1.02 | $1.02 | $1.02 |
| Q2 2024 | 4 | $1.18 | $1.19 | $1.19 |
| Q3 2024 | 3 | $1.18 | $1.20 | $1.19 |
| Q4 2024 | 8 | $1.01 | $1.15 | $1.08 |
| Q1 2025 | 4 | $1.05 | $1.20 | $1.11 |
| Q2 2025 | 2 | $1.39 | $1.48 | $1.42 |
| Q3 2025 | 2 | $1.12 | $1.20 | $1.15 |
| Q4 2025 | 2 | $1.18 | $1.26 | $1.20 |
| Q1 2026 | 1 | $1.26 | $1.35 | $1.29 |
| Q2 2026 | 1 | $1.39 | $1.49 | $1.42 |
| Q3 2026 | 1 | $1.33 | $1.42 | $1.36 |
| Q4 2026 | 1 | $1.27 | $1.36 | $1.30 |
Amedisys, Inc. Earnings Date And Information
Amedisys, Inc. last posted its earnings results on Wednesday, November 6th, 2024. The company reported $1 earnings per share for the quarter, missing analysts' consensus estimates of $1.17 by $0.17. The company had revenue of 587.67 M for the quarter and had revenue of 2.24 B for the year. Amedisys, Inc. has generated $0 earnings per share over the last year ($-0.3 diluted earnings per share) and currently has a price-to-earnings ratio of 23.27. Amedisys, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, February 19th, 2025 based on prior year's report dates.
Amedisys, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/07/2024 | Q3 2024 | $1.27 | $586.75 M | $587.67 M | ||
| 07/25/2024 | Q2 2024 | $0.99 | $578.79 M | $591.19 M | ||
| 04/25/2024 | Q1 2024 | $0.44 | $571.41 M | |||
| 04/26/2024 | Q4 2023 | $1.21 | $570.79 M | |||
| 10/25/2023 | Q3 2023 | $0.80 | $560.23 M | $556.24 M | ||
| 07/27/2023 | Q2 2023 | -$2.46 | $568.18 M | $552.97 M | ||
| 05/04/2023 | Q1 2023 | $0.78 | $556.39 M | |||
| 02/16/2023 | Q4 2022 | $0.98 | $562.06 M | |||
| 10/27/2022 | Q3 2022 | $0.79 | $579.31 M | $557.99 M | ||
| 07/28/2022 | Q2 2022 | $0.91 | $583.12 M | $557.89 M | ||
| 04/28/2022 | Q1 2022 | $0.97 | $545.26 M | |||
| 02/24/2022 | Q4 2021 | $1.04 | $559.32 M | |||
| 11/03/2021 | Q3 2021 | $1.38 | $568.27 M | $553.49 M | ||
| 08/05/2021 | Q2 2021 | $2.46 | $565.48 M | $564.17 M | ||
| 04/29/2021 | Q1 2021 | $1.52 | $537.14 M | |||
| 02/25/2021 | Q4 2020 | $1.38 | $550.71 M | |||
| 10/29/2020 | Q3 2020 | $2.20 | $533.67 M | $544.07 M | ||
| 07/29/2020 | Q2 2020 | $1.07 | $468.41 M | $485.06 M | ||
| 05/07/2020 | Q1 2020 | $0.98 | $491.69 M | |||
| 02/19/2020 | Q4 2019 | $0.86 | $500.68 M |
Amedisys, Inc. Earnings: Frequently Asked Questions
-
When is Amedisys, Inc.'s earnings date?
Amedisys, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, February 19th, 2025 based off last year's report dates.
-
How can I listen to Amedisys, Inc.'s earnings conference call?
The conference call for Amedisys, Inc.'s latest earnings report can be listened to online.
-
How can I read Amedisys, Inc.'s conference call transcript?
The conference call transcript for Amedisys, Inc.'s latest earnings report can be read online.
-
How much revenue does Amedisys, Inc. generate each year?
Amedisys, Inc. (:AMED) has a recorded annual revenue of $2.24 B.
-
How much profit does Amedisys, Inc. generate each year?
Amedisys, Inc. (:AMED) has a recorded net income of $2.24 B. Amedisys, Inc. has generated $-0.3 earnings per share over the last four quarters.
-
What is Amedisys, Inc.'s price-to-earnings ratio?
Amedisys, Inc. (:AMED) has a price-to-earnings ratio of 23.27 and price/earnings-to-growth ratio is 1.7.
